Skip to content
Subscriber Only
Business
Prognosis

U.S. Identifies 28 Blood-Clot Cases After Use of J&J Shot

  • Cases determined among 8.7 million doses administered in U.S.
  • Newest numbers came in CDC presentation posted online
Bloomberg business news
U.S. Clears Pfizer-BioNTech Covid Shot for Adolescents
Updated on

Twenty eight people developed blood clots with low platelets after receiving Johnson & Johnson’s Covid-19 vaccine, according to the Centers for Disease Control and Prevention.

The 28 cases were identified out of 8.7 million doses of J&J’s vaccine administered in the U.S., the CDC said in a presentation posted online Wednesday ahead of a meeting of the agency’s immunization advisory committee. The panel will review the new data on the condition, called thrombosis with thrombocytopenia syndrome.